Doctor David Fitchett
St. Michael's Hospital, Toronto (Canada)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure (EBAC Accredited)
Event: ESC Congress 2017
Topic: Drug therapy
Session type: Satellite Symposium
SGLT2 inhibition in diabetes and heart failure: discuss the evidence
Event: ESC Congress 2016
Topic: Diabetes management
Session type: EBAC Accredited Educational Programme - Experts on the Spot
SGLT2 inhibition, diabetes and CVD: where does this fit in CV risk management?
Event: ESC Congress 2016
Topic: Diabetes management
Session type: EBAC Accredited Educational Programme
ESC 365 is supported by
